Wellnex is undertaking a $16 million capital raising ahead of a dual listing on London's AIM exchange, a focal point ... Read ...

Consumer health care company Haleon plans to invest $54.2 million to upgrade its research and development facility in Richmond’s Northside.

The UK-based consumer healthcare company will be modernizing its facility along Brook Road, where it conducts R&D for such ...

This Fool considers how two low-risk and well-established FTSE shares could offer stability and growth during a period of market volatility.

Both assets are poised to enter registrational studies under accelerated approval pathways, according to Jefferies. GSK to Stay Out of Obesity—but not GLP-1s At JPM25 on Monday, GSK Chief Scientific ...

Haleon, the group behind Sensodyne toothpaste and Centrum vitamins, inched down 0.03 per cent, or 0.1p, to 367p after US pharma giant Pfizer sold 700m shares at 357p each, raising some £2.5billion.

Depemokimab data reveals 72% reduction in hospitalizations; projected sales hit £4 billion. GSK plc GSK expects strong momentum in the specialty business segment to continue with growth from ...

Shares in the maker of Sensodyne, Panadol and Advil ... which was created by the merger of GSK and Pfizer's consumer healthcare businesses in 2019. It was spun off from the British drugmaker ...

Weybridge, England-based Haleon is a consumer healthcare products manufacturer that owns brands such as Sensodyne toothpaste ... a joint venture of Pfizer and GSK PLC's consumer health businesses.

Haleon--which owns brands such as Sensodyne toothpaste, Aquafresh mouthwash and over-the-counter medicines Panadol and Advil--was formed in July 2019 through the merger of GSK and Pfizer's ...

Last October, it sold a $3.3 billion stake in the maker of Sensodyne, while GSK sold its entire stake in May. J.P. Morgan and Morgan Stanley are joint global coordinators and joint bookrunners for the ...